
    
      This is an observational study of unstimulated bone marrow (BM) and filgrastim-mobilized
      peripheral blood stem cell (PBSC) donors. The primary goal is to evaluate the hypothesis that
      the incidence of targeted malignant, thrombotic and autoimmune disorders after unrelated
      hematopoietic stem cell donation are similar between unstimulated BM and filgrastim-mobilized
      PBSC donors. Donors will undergo biennial surveys until study completion. Cases of targeted
      disorders will be reviewed by the medical monitors to confirm the veracity of the report.
    
  